Market revenue in 2023 | USD 221.1 million |
Market revenue in 2030 | USD 446.2 million |
Growth rate | 10.6% (CAGR from 2023 to 2030) |
Largest segment | Dna chips |
Fastest growing segment | Lab-on-chip |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Tissue Arrays, Cell Arrays, DNA Chips, Lab-on-chip, Protein Chips |
Key market players worldwide | Agilent Technologies Inc, PerkinElmer, Illumina Inc, Bio-Rad Laboratories Inc, Standard BioTools Inc, GE HealthCare Technologies Inc Common Stock, Thermo Fisher Scientific Inc, Qiagen NV, Randox |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biochip market will help companies and investors design strategic landscapes.
Dna chips was the largest segment with a revenue share of 38.94% in 2024. Horizon Databook has segmented the Spain biochip market based on tissue arrays, cell arrays, dna chips, lab-on-chip, protein chips covering the revenue growth of each sub-segment from 2018 to 2030.
The country’s supportive healthcare policies & initiatives to increase public awareness and monitor the disease rate are expected to increase the demand for advanced therapeutics in the country. According to the Global Competitiveness 2020 Report, the World Economic Forum placed Spain as the country with the world's best healthcare system.
Key players in the market are adopting strategies such as collaborations, launch of products, and acquisitions to maintain their position in the market. For instance, in July 2022, one of the startup DNA chip firms in Spain won USD 300,000 from a new fund. This funding was to improve the application of DNA chips in disease progression and diagnostics.
Moreover, supportive government legislation and favorable policies for research are some of the other factors contributing to market expansion. For instance, in December 2022 two researchers from Spain joined CNIO to lead Proteomics and Confocal Microscopy Units.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain biochip market, including forecasts for subscribers. This country databook contains high-level insights into Spain biochip market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account